SlideShare une entreprise Scribd logo
1  sur  5
Télécharger pour lire hors ligne
.noitacifitreC s'tsylanA eht gnidulcni ,stnemetatS erusolcsiD rof 5 ot 2 segap ot refer esaelP
                                              moc.omb@knirbmut.semaj                                                                   :liamE
                                         5914-588-212 knirbmuT semaJ                                                            :eta icos s A
                                                 moc.omb@ ttel z a h.trebor                                                            :liamE
                                           1 9 0 4 - 5 8 8 - 2 1 2 t t el z a H t r e b o R                                         :tsy l a n A
                                               slacituecamra hP y tla icepS                                                 :e maN rotceS
                                               00.92$/mrofrep tuO/30 .51$                                             :tegraT/gnita R/ec irP
                                                         )A DLC( a taD l acin ilC                                                :y napmoC
             .serahs ADLC no gnitar MROFREPTUO ruo niatniam ew ;srotsevni rof ytinutroppo
g ni si m orp a si ataD lacin ilC ,dy rbiiV fo lavorppa elc y c tsrif elbakra m er eh t htiW                                                            ∗
                                                                                            .ataD lacin ilC fo es ahcrup th girtuo
n a fo lait netop eht ro/dna , ypareh t gn is i m orp eht tekra m ot y n apm oc lacitu eca m rahp
r e h t o n a h ti w e c n a i l l a r o j a m a f o d o o hi l e ki l e h t s e s a e r c n i y ll a i r e t a m l a v o r p p a d y r b i i V e h T   ∗
             .dy rbiiV rof noitaitner e f fid lanoitidda emos edivorp o t tn eicif fus eb ot ti eveileb eW
.noitcnuf lauxes ni segnahc tsedom detroper-fles tneitap no noitamrofni sedulcni gnilebaL                                                               ∗
                                                                                  .tn empole ved ni dna devorppa y ltnerruc
htob ,stnasserpeditna rehto ot derapmoc noitaitnereffid lufgninaem edivorp ot ytiliba
e h t s a h , m s i n a h c e m t s i n o g a l a i t r a p a , 1 - T H 5 / I R S S l a u d e u q i n u s' d y r b i i V e v e i l e b e W              ∗
                                                                                                              .dn uopm oc eh t fo y tivitca
eht g nirocsredn u ,)I-IGC dna SIGC( tn e m evorp m I dna ss enllI f o y tirev eS s noisserp m I
l a b o l G l a c i n i l C e h t d n a , ) A - M A H ( y t e i x n A r o f e l a c S g ni t a R n o t l i m a H e h t , ) 7 1
- D - M A H ( e l a c S g ni t a R n o i s s e r p e D n o t l i m a H e h t n i s t n e m e v o r p m i t n a c i f i n g i s d e w o h s o s l a
s eidu ts 3 esahP eht ,noitidda nI .s kee w t hgie ta erocs latot ela cS g n itaR n oisserpeD grebs A
- y rem og tnoM ni eg n ahc fo tniopdne y ra m irp n i tn e m ev orp m i tnaci fin gis a g n i w ohs s eiduts
3 e s a h P e v i t i s o p o w t f o s t l u s e r e h t n o d e s a b s i l a v o r p p a l l u f e l c y c t s ri f e l b a k r a m e r s i h T      ∗
                                                                                                                                         :weiV ruO
                                                                    .redrosid evisserped
rojam/noisserped rof )enodozaliv( dyrbiiV s'ataD lacinilC ot lavorppa lluf sevig ADF                                                                                           Flash:
                                                                     Vilazodone Fully Approved for Depression - Our Quick Take
                                                                                                                                                                  )QADSAN-ADLC(
                                                                                                  Clinical Data (Outperform)
                                                                                                                                                            11 02 ,12 y rau naJ , y adirF
hsalF                                                                                                            stekraM latipaC OMB

                                        CLINICAL DATA INC NEW (CLDA)
                                                                                                       Target Price(US$)
                       Quarterly Price (US$)
                                                                                                       Share Price(US$)
                                                                           30                                                                   30

 25                                                                 25
                                                                           25                                                                   25

 20                                                                 20     20                                                                   20

 15                                                                 15     15                                                                   15
                                                                                                                 1) OP
 10                                                                 10     10                                                                   10


  5                                                                 5       5                                                                   5


                                                                            0                                                                   0

                 CLDA Relative to S&P 500                                                   CLDA Relative to S&P 500
                 CLDA Relative to Health Care Equipment                                     CLDA Relative to Health Care Equipment
                                                                          140                                                                   140
800                                                                 800
                                                                          120                                                                   120
600                                                                 600
                                                                          100                                                                   100
400                                                                 400
                                                                           80                                                                   80

200                                                                 200    60                                                                   60

                                                                           40                                                                   40
  1980    1985      1990      1995        2000        2005   2010                2008                   2009                   2010

                       EPS (4 Qtr Trailing) - (US$)                                     CLDA Relative to S&P 500 Y/Y (%)
                       Price / Earnings                                                 CLDA Relative to Health Care Equipment Y/Y (%)
 10                                                                 100   100                                                                   100

  0                                                                 50
                                                                    0     -100                                                                  -100
  1980    1985      1990      1995        2000        2005   2010                2008                  2009                   2010




                                                                                        CLDA - Rating as of 8-Feb-08 = NR


                                                                                            Date              Rating Change    Share Price
                                                                                        1   2-Dec-09          NR to OP         $16.09




                                                                                                            Last Daily Data Point: January 20, 2011




  2 eg aP • hsalF
3 eg aP • hsalF
                                              fdp.smetsys_gnitar_roirp/9002/stnemucod/moc.stekramlatipacomb.labolghcraeser//:ptth
                                                                                        smetsyS sgnitaR stekraM latipaC OMB roirP
                      .3H1 X5M ,oiratnO ,otnoroT ,ecalP naidanaC tsriF 1 ,stekraM latipaC OMB ,tnemtrapeD lairotidE ro 63001
  YN ,kroY weN ,erauqS semiT 3 ,stekraM latipaC OMB ,tnemtrapeD lairotidE ot etirw ro psa.cilbuP_erusolcsiD_ynapmoC
  /moc.stekramlatipacomb.labolghcraeser//:ptth ot og esaelp ,troper siht ni dessucsid skcots eht no serusolcsiD tnatropmI rehtO roF
                                                                                                           serusolcsiD tnatropmI rehtO
                                                                                                                             .gnitar
         kciP poT eht decalper evah )llams SU ,egral SU dna ;evitatitnauq ,emocni ,eulav ,htworg ,llams ,egral naidanaC( sevitcejbo
     tnereffid ot gnidrocca saedi tseb ruo ot srotsevni ediug stsil 51 poT thgie stekraM latipaC OMB .ynapmoc hcae rof etairporppa
  sa ,etisopmoC qadsaN ,005 P&S ,xednI etisopmoC XST/P&S eht sa hcus xedni kramhcneb a yb derusaem si ecnamrofrep tekraM
                                                                     .detcirtser yltnerruc si hcraeser fo noitanimessiD – detcirtseR = R
                                                                                                              ;emit siht ta gnitar oN = RN
                                                                                                            ;tnemtsevni evitaluceps = )S(
                                                                          ;tekram eht mrofreprednu ot tsaceroF - mrofreprednU = dnU
                                                          ;tekram eht htiw enil ni ylhguor mrofrep ot tsaceroF - mrofreP tekraM = tkM
                                                                                 ;tekram eht mrofreptuo ot tsaceroF - mrofreptuO = PO
                                                                                        :snoitinifed metsys sgnitar gniwollof eht esu eW
                                                                                                                 yeK rotceS dna sgnitaR
                                                                .stneilc gniknaB tnemtsevnI fo egatnecrep sa secivres gniknaB
  tnemtsevnI rof noitasnepmoc deviecer sah stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR * ** **
                     .stsylana hcraeser ytiuqe stekraM latipaC OMB yb derevoc seinapmoc lla fo noitubirtsid gnitar stcelfeR ** **
                                                   .stneilc gniknaB tnemtsevnI fo egatnecrep sa secivres gniknaB tnemtsevnI
  rof noitasnepmoc deviecer sah .proC stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR * **
                                                             .yrogetac sgnitar nihtiw egatnecrep sa secivres gniknaB tnemtsevnI
  rof noitasnepmoc deviecer sah .proC stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR                  **
              .stsylana hcraeser ytiuqe .proC stekraM latipaC OMB yb derevoc seinapmoc lla fo noitubirtsid gnitar stcelfeR           *
      %1.5            %1.3              %9.3              %6.1             %3.8             %4.2          mrofreprednU         lleS
     %7.14           %8.15             %5.75             %4.95             %0.21           %3.26         mrofreP tekraM       dloH
     %2.35           %1.54             %6.83             %1.93             %0.41           %3.53            mrofreptuO         yuB
    esrevinU * ****stneilC BI * ***esrevinU ***stneilC BI **stneilC BI                   *esrevinU         gnitaR OMB       yrogetaC
    enimratS       MCOMB              MCOMB          SU MCOMB SU MCOMB SU MCOMB                                              gnitaR
                                                                                         )0102 ,13 rebmeceD( sgnitaR fo noitubirtsiD
                                                                                                stcudorp gnitset citeneg noilimaF
  eht fo gnitekram dna ,gnicnanif ,seipareht enilepip fo tnempoleved lufsseccus eht edulcni tegrat ecirp ruo ot sksiR :sksiR
                                                         sisylana strap eht fo mus ruo no desab si tegrat ecirp ruO :ygolodohteM
                                                                                          tegraT ecirP ruO ot sksiR dna ygolodohteM
                                                                    .ytiruces siht ni tekram a sekam stekraM latipaC OMB :9 erusolcsiD
                                                                       .secivreS gniknaB tnemtsevnI :shtnom 21 tsap eht nihtiw etailiffa
na ro .dtL MC OMB ,.proC stekraM latipaC OMB ,.cnI snruB ttibseN OMB fo )tneilc a saw ro( tneilc a si reussi sihT :6 erusolcsiD
                                                                                                              .shtnom 21 tsap eht nihtiw
reussi siht morf secivres gniknab tnemtsevni rof noitasnepmoc deviecer sah etailiffa na ro stekraM latipaC OMB :4 erusolcsiD
                                                                                                                        .shtnom 21 tsap
eht nihtiw reussi siht ot tcepser htiw seitiruces fo gnireffo cilbup a deganam-oc ro deganam sah stekraM latipaC OMB :3 erusolcsiD
 .shtnom 21 tsap eht nihtiw reussi siht ot tcepser htiw secivres gniknab tnemtsevni dedivorp sah stekraM latipaC OMB :2 erusolcsiD
   .shtnom 21 tsap eht nihtiw reussi siht ot tcepser htiw ytilibail gnitirwrednu na nekatrednu sah stekraM latipaC OMB :1 erusolcsiD
                                                                                                           erusolcsiD cificepS ynapmoC
                                                                                  .stneilc ot ecivres dna ,setamitse sgninrae fo ycarucca
  ,snoitadnemmocer fo ecnamrofrep ,stneilc ot saedi fo noitacinummoc ni dna saedi wen gnitareneg ni ssenevitceffe no desab
  si hcraeser rof noitasnepmoC .secivres gniknab tnemtsevni fo ytilibatiforp llarevo eht sedulcni hcihw ,setailiffa rieht dna stekraM
  latipaC OMB fo ytilibatiforp llarevo eht )srotcaf rehto gnoma( nopu desab detasnepmoc era troper siht deraperp ohw stsylanA
                                                                                     .troper siht ni desserpxe sweiv ro snoitadnemmocer
  cificeps eht ot detaler ,yltceridni ro yltcerid ,eb lliw ro ,si ,saw noitasnepmoc ym fo trap on taht yfitrec osla I .sreussi ro seitiruces
  tcejbus eht tuoba sweiv lanosrep ym tcelfer yletarucca troper siht ni desserpxe sweiv eht taht yfitrec ybereh ,ttelzaH treboR ,I
                                                                                                                  noitacifitreC s'tsylanA
                                                                                                            se rusol csiD tnatropmI
  stekraM latipaC OMB                                                                                                               hsalF
4 eg aP • hsalF
                                                          .stneilc liater ,ot no dessap ro deussi eb ton yam dna fo esu eht rof dednetni
ton era foereh stnetnoc ehT .)”snosrep tnaveler“ sa ot derrefer rehtegot snosrep hcus lla( redrO eht fo )d( ot )a()2(94 elcitrA
nihtiw gnillaf seititne htrow ten hgih )II( ro )”redrO“ eht( 5002 redrO )noitomorP laicnaniF( 0002 tcA stekraM dna secivreS
laicnaniF eht fo )5(91 elcitrA nihtiw gnillaf stnemtsevni ot gnitaler srettam ni ecneirepxe lanoisseforp evah ohw snosrep )I(
,ot no dessap ro deussi eb ylno yam dna ,fo esu eht rof ylelos dednetni era foereh stnetnoc ehT .ytirohtuA secivreS laicnaniF eht
yb detaluger dna desirohtua si hcihw detimiL stekraM latipaC OMB yb dehsilbup si tnemucod siht KU eht nI :stnediseR .K.U oT
                                                                               .dtL seitiruceS snruB ttibseN OMB ro/dna .proC stekraM
latipaC OMB hguorht os od dluohs niereh dessucsid ytiruces yna ni snoitcasnart tceffe ot gnihsiw nosrep .S.U ynA .laertnoM
fo knaB fo seitiruces ot srefer ti taht tnetxe eht ot tpecxe ,niereh stnetnoc eht rof ytilibisnopser tpecca dna stnediser .S.U ot troper
siht hsinruf ,BN OMB fo setailiffa ,.dtL seitiruceS snruB ttibseN OMB ro/dna .proC stekraM latipaC OMB :stnediseR .S.U oT
                                                                                          .dtL/eetL snruB ttibseN OMB ro/dna .cnI snruB
ttibseN OMB hguorht os od dluohs troper siht ni dedulcni seitiruces eht fo yna ni snoitcasnart tceffe ot gnihsiw nosrep naidanaC
ynA .evoba tuo tes smret eht ot tcejbus niereh stnetnoc eht rof ytilibisnopser tpecca dna stnediser naidanaC ot troper siht hsinruf
,.proC stekraM latipaC OMB fo setailiffa ,.dtL/eetL snruB ttibseN OMB dna .cnI snruB ttibseN OMB :stnediseR naidanaC oT
                                                                                                                    srettaM lanoitiddA
                                                                                       .niereh dessucsid sreussi fo seitiruces lles ro yub
ot ton ro rehtehw gnitaulave ni troper siht no ylelos yler ton dluohs dna tseretni fo tcilfnoc a evah yam setailiffa sti ro stekraM
latipaC OMB taht emussa dluohs redaer ehT .noereht desab stnemurtsni evitavired rehto ro serutuf ,snoitpo ni ro seitiruces
detaler ,niereh dessucsid seitiruces eht fo ynam ni noitisop trohs ro gnol a evah seeyolpme ro srotcerid ,sreciffo ,setailiffa sti
ro stekraM latipaC OMB .sisab lapicnirp a no troper siht ni denoitnem sreussi fo seitiruces eht sremotsuc ot lles ro morf yub lliw
setailiffa sti ro stekraM latipaC OMB .ytiruces yna yub ot reffo na fo noitaticilos eht ro lles ot reffo na ton si dna ylno sesoprup
noitamrofni rof si lairetam sihT .rotsevni yna fo sdeen tnemtsevni ralucitrap eht teem ot dengised ecivda sa deurtsnoc eb ton
dluohs ,sevitcejbo tneilc laudividni fo esuaceb dna ,snoisiced tnemtsevni fo sisab yramirp eht sa desu eb ot dednetni ton si troper
siht ni noitamrofni ehT .troper siht ni detcelfer ton si taht setailiffa sti ro stekraM latipaC OMB ot elbaliava eb yam noitamrofnI
.stnetnoc sti ro troper siht ,no ecnailer ro ,fo esu yna morf gnisira ssol yna rof reveostahw ytilibail on stpecca dna niereh
deniatnoc snoissimo dna srorre yna rof ytilibisnopser on sekat ,foereht tcepser ni ,deilpmi ro sserpxe ,ytnarraw ro noitatneserper
on sekam stekraM latipaC OMB ,revewoH .etelpmoc dna etarucca era taht snoinipo dna noitamrofni niatnoc dna elbailer
era eveileb ew taht secruos morf devired ro delipmoc neeb evah stnetnoc eht taht erusne ot sruovaedne stekraM latipaC OMB
.eciton tuohtiw egnahc ot tcejbus era dna troper siht fo etad eht fo sa stekraM latipaC OMB fo esoht era troper siht ni deniatnoc
snoitcejorp dna setamitse ,snoinipo ehT .stekraM latipaC OMB yb derevoc sreussi ynam ,ot secivres detarenumer rehto edivorp
ro ,htiw stnemegnarra gnidnel sah )”puorG laicnaniF OMB“( seiraidisbus sti ro laertnoM fo knaB .setailiffa era .proC stekraM
latipaC OMB dna .dtL stekraM latipaC OMB ,.cnI snruB ttibseN OMB .S.U eht ni .proC stekraM latipaC OMB dna .K.U eht
ni .dtL stekraM latipaC OMB ,.dtL/.eétL snruB ttibseN OMB dna .cnI snruB ttibseN OMB seiraidisbus sti dna laertnoM fo knaB
fo mra elaselohw eht sedulcni hcihw ,puorG gniknaB tnemtsevnI OMB eht yb desu eman edart a si ”stekraM latipaC OMB“
                                                                                                                   remialcsiD lareneG
                                                              .psa.cilbuP_tnemetatS_tcilfnoC/moc.stekramlatipacomb.labolghcraeser//:ptth
ta elbaliava si hcihw hcraeser tnemtsevni htiw noitcennoc ni tseretni fo stcilfnoc gniganam rof
ycilop gnicaf cilbup ruo ni deniatnoc si tseretni fo stcilfnoc seganam dna seifitnedi puorG laicnaniF OMB woh fo noitpircsed lareneg A
                                                                                                                    tnemetatS tcilfnoC
                                                                                  .noitamrofni erom rof nosrepselas lanoitutitsni
ro rosivda tnemtsevni ruoy tcatnoc esaelP .liam raluger ro liame aiv rucco yam noitanimessid lanoitiddA .hcraeser ruo ot deltitne
spuorg tneilc stekraM latipaC OMB lla ot emit emas eht ta elbaliava ylediw edam si hcraeser ruo fo llA .moc.stekraMehT
dna ,QI latipaC ,teStcaF ,grebmoolB ,sretueR ,tceriD hcraeseR LLAC TSRIF ,LLAC TSRIF aiv hcraeser ruo eviecer
osla yam stneilc lanoitutitsnI ./hcraeser/moc.stekramlatipacomb//:ptth etis bew ruo aiv elbaliava era snoitacilbup hcraeser ruO
                                                                                                           hcraeseR fo noitanimessiD
stekraM latipaC OMB                                                                                                               hsalF
5 eg aP • hsalF
                                            Financial Group             A member of BMO
                                        .PROC STEKRAM LATIPAC OMB 1102 THGIRYPOC©
                                                                                laertnoM fo knaB kramedarT MT
                    .erehwesle dna adanaC ,setatS detinU eht ni laertnoM fo knaB fo kramedart deretsigeR ®
    .esnecil rednu desu ,laertnoM fo knaB fo kramedart deretsiger a si ")lobmys lednuor raB-M( OMB" .esnecil rednu desu ,laertnoM fo
knaB fo kramedart a si ”stekraM latipaC OMB“ .esnecil rednu desu ,detimiL noitaroproC snruB ttibseN OMB fo kramedart deretsiger
a si ”snruB ttibseN“ .ailartsuA dna eporuE ni detimiL stekraM latipaC OMB dna ,adanaC ni )FPIC rebmeM( .dtL/eétL snruB
ttibseN OMB dna ,)ARNIF fo rebmem dna deretsiger .S.U( detimiL seitiruceS snruB ttibseN OMB ,aisA dna eporuE ,adanaC ni )FPIC
rebmeM( .cnI snruB ttibseN OMB ,.S.U eht ni )CPIS rebmeM( .cnI TSKG stekraM latipaC OMB dna .proC gnidarT snruB ttibseN
OMB ,)CPIS rebmeM( .proC stekraM latipaC OMB fo sessenisub relaed rekorb lanoitutitsni eht dna ,clP dnalerI OMB dna .A.N sirraH
,laertnoM fo knaB fo sessenisub gniknab elaselohw eht rof puorG laicnaniF OMB yb desu eman edart a si stekraM latipaC OMB
                                                                                                    .stekraM latipaC OMB hguorht SU eht dna
adanaC ni dedivorp era secivres gniknab etaroproc dna tnemtsevnI .A.N sirraH hguorht devres era stneilc liater ,setatS detinU eht nI .snruB
ttibseN OMB dna laertnoM fo knaB OMB hguorht stneilc liater naidanaC sevres OMB .stcudorp gniknab etaroproc dna tnemtsevni dna
,tnemeganam htlaew ,gniknab liater fo egnar a gnireffo redivorp secivres laicnanif detargetni na si )OMB :XST ,ESYN( puorG laicnaniF OMB
                                   TSEUQER NOPU ELBALIAVA SI NOITAMROFNI LANOITIDDA
stekraM latipaC OMB                                                                                                                hsalF

Contenu connexe

Plus de James Hilbert

Asco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_finalAsco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_final
James Hilbert
 
Company presentation
Company presentationCompany presentation
Company presentation
James Hilbert
 
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
James Hilbert
 
Transforming time for prostate cancer therapies
Transforming time for prostate cancer therapiesTransforming time for prostate cancer therapies
Transforming time for prostate cancer therapies
James Hilbert
 
1 s2.0-s1470204510701327-main
1 s2.0-s1470204510701327-main1 s2.0-s1470204510701327-main
1 s2.0-s1470204510701327-main
James Hilbert
 
Phase 2b emerge study of cdx 011
Phase 2b emerge study of cdx 011Phase 2b emerge study of cdx 011
Phase 2b emerge study of cdx 011
James Hilbert
 
Bmn 110 ph12 results
Bmn 110 ph12 resultsBmn 110 ph12 results
Bmn 110 ph12 results
James Hilbert
 
The combos study an expert interview with william s
The combos study  an expert interview with william sThe combos study  an expert interview with william s
The combos study an expert interview with william s
James Hilbert
 
$MAPP Phase 3 results
$MAPP Phase 3 results$MAPP Phase 3 results
$MAPP Phase 3 results
James Hilbert
 
Novel therapies in hcc
Novel therapies in hccNovel therapies in hcc
Novel therapies in hcc
James Hilbert
 
Docetaxel Versus Docetaxel/Cisplatin in NSCLC
Docetaxel Versus Docetaxel/Cisplatin in NSCLCDocetaxel Versus Docetaxel/Cisplatin in NSCLC
Docetaxel Versus Docetaxel/Cisplatin in NSCLC
James Hilbert
 
Second or third additional chemotherapy drug for non-small cell lung cancer i...
Second or third additional chemotherapy drug for non-small cell lung cancer i...Second or third additional chemotherapy drug for non-small cell lung cancer i...
Second or third additional chemotherapy drug for non-small cell lung cancer i...
James Hilbert
 

Plus de James Hilbert (20)

Ttrsc
TtrscTtrsc
Ttrsc
 
Alny
AlnyAlny
Alny
 
Asco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_finalAsco 2012 abstract_45010_oral_final
Asco 2012 abstract_45010_oral_final
 
Company presentation
Company presentationCompany presentation
Company presentation
 
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
5 understanding some basic trial designs in sarcomas (inclusive a placebo one...
 
Transforming time for prostate cancer therapies
Transforming time for prostate cancer therapiesTransforming time for prostate cancer therapies
Transforming time for prostate cancer therapies
 
1 s2.0-s1470204510701327-main
1 s2.0-s1470204510701327-main1 s2.0-s1470204510701327-main
1 s2.0-s1470204510701327-main
 
Phase 2b emerge study of cdx 011
Phase 2b emerge study of cdx 011Phase 2b emerge study of cdx 011
Phase 2b emerge study of cdx 011
 
Bmn 110 ph12 results
Bmn 110 ph12 resultsBmn 110 ph12 results
Bmn 110 ph12 results
 
The combos study an expert interview with william s
The combos study  an expert interview with william sThe combos study  an expert interview with william s
The combos study an expert interview with william s
 
$MAPP Phase 3 results
$MAPP Phase 3 results$MAPP Phase 3 results
$MAPP Phase 3 results
 
Novel therapies in hcc
Novel therapies in hccNovel therapies in hcc
Novel therapies in hcc
 
12702889
1270288912702889
12702889
 
Nsclc 2nd line
Nsclc 2nd lineNsclc 2nd line
Nsclc 2nd line
 
Docetaxel Versus Docetaxel/Cisplatin in NSCLC
Docetaxel Versus Docetaxel/Cisplatin in NSCLCDocetaxel Versus Docetaxel/Cisplatin in NSCLC
Docetaxel Versus Docetaxel/Cisplatin in NSCLC
 
Second or third additional chemotherapy drug for non-small cell lung cancer i...
Second or third additional chemotherapy drug for non-small cell lung cancer i...Second or third additional chemotherapy drug for non-small cell lung cancer i...
Second or third additional chemotherapy drug for non-small cell lung cancer i...
 
$SNGX Nnational.2.1.2010
$SNGX Nnational.2.1.2010$SNGX Nnational.2.1.2010
$SNGX Nnational.2.1.2010
 
Cbli 2011 05 25 barda
Cbli 2011 05 25 bardaCbli 2011 05 25 barda
Cbli 2011 05 25 barda
 
$PSTI Oppenheimer
$PSTI Oppenheimer$PSTI Oppenheimer
$PSTI Oppenheimer
 
GS Weekly Options Watch - May 11th
GS Weekly Options Watch - May 11thGS Weekly Options Watch - May 11th
GS Weekly Options Watch - May 11th
 

Clda bmo01

  • 1. .noitacifitreC s'tsylanA eht gnidulcni ,stnemetatS erusolcsiD rof 5 ot 2 segap ot refer esaelP moc.omb@knirbmut.semaj :liamE 5914-588-212 knirbmuT semaJ :eta icos s A moc.omb@ ttel z a h.trebor :liamE 1 9 0 4 - 5 8 8 - 2 1 2 t t el z a H t r e b o R :tsy l a n A slacituecamra hP y tla icepS :e maN rotceS 00.92$/mrofrep tuO/30 .51$ :tegraT/gnita R/ec irP )A DLC( a taD l acin ilC :y napmoC .serahs ADLC no gnitar MROFREPTUO ruo niatniam ew ;srotsevni rof ytinutroppo g ni si m orp a si ataD lacin ilC ,dy rbiiV fo lavorppa elc y c tsrif elbakra m er eh t htiW ∗ .ataD lacin ilC fo es ahcrup th girtuo n a fo lait netop eht ro/dna , ypareh t gn is i m orp eht tekra m ot y n apm oc lacitu eca m rahp r e h t o n a h ti w e c n a i l l a r o j a m a f o d o o hi l e ki l e h t s e s a e r c n i y ll a i r e t a m l a v o r p p a d y r b i i V e h T ∗ .dy rbiiV rof noitaitner e f fid lanoitidda emos edivorp o t tn eicif fus eb ot ti eveileb eW .noitcnuf lauxes ni segnahc tsedom detroper-fles tneitap no noitamrofni sedulcni gnilebaL ∗ .tn empole ved ni dna devorppa y ltnerruc htob ,stnasserpeditna rehto ot derapmoc noitaitnereffid lufgninaem edivorp ot ytiliba e h t s a h , m s i n a h c e m t s i n o g a l a i t r a p a , 1 - T H 5 / I R S S l a u d e u q i n u s' d y r b i i V e v e i l e b e W ∗ .dn uopm oc eh t fo y tivitca eht g nirocsredn u ,)I-IGC dna SIGC( tn e m evorp m I dna ss enllI f o y tirev eS s noisserp m I l a b o l G l a c i n i l C e h t d n a , ) A - M A H ( y t e i x n A r o f e l a c S g ni t a R n o t l i m a H e h t , ) 7 1 - D - M A H ( e l a c S g ni t a R n o i s s e r p e D n o t l i m a H e h t n i s t n e m e v o r p m i t n a c i f i n g i s d e w o h s o s l a s eidu ts 3 esahP eht ,noitidda nI .s kee w t hgie ta erocs latot ela cS g n itaR n oisserpeD grebs A - y rem og tnoM ni eg n ahc fo tniopdne y ra m irp n i tn e m ev orp m i tnaci fin gis a g n i w ohs s eiduts 3 e s a h P e v i t i s o p o w t f o s t l u s e r e h t n o d e s a b s i l a v o r p p a l l u f e l c y c t s ri f e l b a k r a m e r s i h T ∗ :weiV ruO .redrosid evisserped rojam/noisserped rof )enodozaliv( dyrbiiV s'ataD lacinilC ot lavorppa lluf sevig ADF Flash: Vilazodone Fully Approved for Depression - Our Quick Take )QADSAN-ADLC( Clinical Data (Outperform) 11 02 ,12 y rau naJ , y adirF
  • 2. hsalF stekraM latipaC OMB CLINICAL DATA INC NEW (CLDA) Target Price(US$) Quarterly Price (US$) Share Price(US$) 30 30 25 25 25 25 20 20 20 20 15 15 15 15 1) OP 10 10 10 10 5 5 5 5 0 0 CLDA Relative to S&P 500 CLDA Relative to S&P 500 CLDA Relative to Health Care Equipment CLDA Relative to Health Care Equipment 140 140 800 800 120 120 600 600 100 100 400 400 80 80 200 200 60 60 40 40 1980 1985 1990 1995 2000 2005 2010 2008 2009 2010 EPS (4 Qtr Trailing) - (US$) CLDA Relative to S&P 500 Y/Y (%) Price / Earnings CLDA Relative to Health Care Equipment Y/Y (%) 10 100 100 100 0 50 0 -100 -100 1980 1985 1990 1995 2000 2005 2010 2008 2009 2010 CLDA - Rating as of 8-Feb-08 = NR Date Rating Change Share Price 1 2-Dec-09 NR to OP $16.09 Last Daily Data Point: January 20, 2011 2 eg aP • hsalF
  • 3. 3 eg aP • hsalF fdp.smetsys_gnitar_roirp/9002/stnemucod/moc.stekramlatipacomb.labolghcraeser//:ptth smetsyS sgnitaR stekraM latipaC OMB roirP .3H1 X5M ,oiratnO ,otnoroT ,ecalP naidanaC tsriF 1 ,stekraM latipaC OMB ,tnemtrapeD lairotidE ro 63001 YN ,kroY weN ,erauqS semiT 3 ,stekraM latipaC OMB ,tnemtrapeD lairotidE ot etirw ro psa.cilbuP_erusolcsiD_ynapmoC /moc.stekramlatipacomb.labolghcraeser//:ptth ot og esaelp ,troper siht ni dessucsid skcots eht no serusolcsiD tnatropmI rehtO roF serusolcsiD tnatropmI rehtO .gnitar kciP poT eht decalper evah )llams SU ,egral SU dna ;evitatitnauq ,emocni ,eulav ,htworg ,llams ,egral naidanaC( sevitcejbo tnereffid ot gnidrocca saedi tseb ruo ot srotsevni ediug stsil 51 poT thgie stekraM latipaC OMB .ynapmoc hcae rof etairporppa sa ,etisopmoC qadsaN ,005 P&S ,xednI etisopmoC XST/P&S eht sa hcus xedni kramhcneb a yb derusaem si ecnamrofrep tekraM .detcirtser yltnerruc si hcraeser fo noitanimessiD – detcirtseR = R ;emit siht ta gnitar oN = RN ;tnemtsevni evitaluceps = )S( ;tekram eht mrofreprednu ot tsaceroF - mrofreprednU = dnU ;tekram eht htiw enil ni ylhguor mrofrep ot tsaceroF - mrofreP tekraM = tkM ;tekram eht mrofreptuo ot tsaceroF - mrofreptuO = PO :snoitinifed metsys sgnitar gniwollof eht esu eW yeK rotceS dna sgnitaR .stneilc gniknaB tnemtsevnI fo egatnecrep sa secivres gniknaB tnemtsevnI rof noitasnepmoc deviecer sah stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR * ** ** .stsylana hcraeser ytiuqe stekraM latipaC OMB yb derevoc seinapmoc lla fo noitubirtsid gnitar stcelfeR ** ** .stneilc gniknaB tnemtsevnI fo egatnecrep sa secivres gniknaB tnemtsevnI rof noitasnepmoc deviecer sah .proC stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR * ** .yrogetac sgnitar nihtiw egatnecrep sa secivres gniknaB tnemtsevnI rof noitasnepmoc deviecer sah .proC stekraM latipaC OMB hcihw morf seinapmoc lla fo noitubirtsid gnitar stcelfeR ** .stsylana hcraeser ytiuqe .proC stekraM latipaC OMB yb derevoc seinapmoc lla fo noitubirtsid gnitar stcelfeR * %1.5 %1.3 %9.3 %6.1 %3.8 %4.2 mrofreprednU lleS %7.14 %8.15 %5.75 %4.95 %0.21 %3.26 mrofreP tekraM dloH %2.35 %1.54 %6.83 %1.93 %0.41 %3.53 mrofreptuO yuB esrevinU * ****stneilC BI * ***esrevinU ***stneilC BI **stneilC BI *esrevinU gnitaR OMB yrogetaC enimratS MCOMB MCOMB SU MCOMB SU MCOMB SU MCOMB gnitaR )0102 ,13 rebmeceD( sgnitaR fo noitubirtsiD stcudorp gnitset citeneg noilimaF eht fo gnitekram dna ,gnicnanif ,seipareht enilepip fo tnempoleved lufsseccus eht edulcni tegrat ecirp ruo ot sksiR :sksiR sisylana strap eht fo mus ruo no desab si tegrat ecirp ruO :ygolodohteM tegraT ecirP ruO ot sksiR dna ygolodohteM .ytiruces siht ni tekram a sekam stekraM latipaC OMB :9 erusolcsiD .secivreS gniknaB tnemtsevnI :shtnom 21 tsap eht nihtiw etailiffa na ro .dtL MC OMB ,.proC stekraM latipaC OMB ,.cnI snruB ttibseN OMB fo )tneilc a saw ro( tneilc a si reussi sihT :6 erusolcsiD .shtnom 21 tsap eht nihtiw reussi siht morf secivres gniknab tnemtsevni rof noitasnepmoc deviecer sah etailiffa na ro stekraM latipaC OMB :4 erusolcsiD .shtnom 21 tsap eht nihtiw reussi siht ot tcepser htiw seitiruces fo gnireffo cilbup a deganam-oc ro deganam sah stekraM latipaC OMB :3 erusolcsiD .shtnom 21 tsap eht nihtiw reussi siht ot tcepser htiw secivres gniknab tnemtsevni dedivorp sah stekraM latipaC OMB :2 erusolcsiD .shtnom 21 tsap eht nihtiw reussi siht ot tcepser htiw ytilibail gnitirwrednu na nekatrednu sah stekraM latipaC OMB :1 erusolcsiD erusolcsiD cificepS ynapmoC .stneilc ot ecivres dna ,setamitse sgninrae fo ycarucca ,snoitadnemmocer fo ecnamrofrep ,stneilc ot saedi fo noitacinummoc ni dna saedi wen gnitareneg ni ssenevitceffe no desab si hcraeser rof noitasnepmoC .secivres gniknab tnemtsevni fo ytilibatiforp llarevo eht sedulcni hcihw ,setailiffa rieht dna stekraM latipaC OMB fo ytilibatiforp llarevo eht )srotcaf rehto gnoma( nopu desab detasnepmoc era troper siht deraperp ohw stsylanA .troper siht ni desserpxe sweiv ro snoitadnemmocer cificeps eht ot detaler ,yltceridni ro yltcerid ,eb lliw ro ,si ,saw noitasnepmoc ym fo trap on taht yfitrec osla I .sreussi ro seitiruces tcejbus eht tuoba sweiv lanosrep ym tcelfer yletarucca troper siht ni desserpxe sweiv eht taht yfitrec ybereh ,ttelzaH treboR ,I noitacifitreC s'tsylanA se rusol csiD tnatropmI stekraM latipaC OMB hsalF
  • 4. 4 eg aP • hsalF .stneilc liater ,ot no dessap ro deussi eb ton yam dna fo esu eht rof dednetni ton era foereh stnetnoc ehT .)”snosrep tnaveler“ sa ot derrefer rehtegot snosrep hcus lla( redrO eht fo )d( ot )a()2(94 elcitrA nihtiw gnillaf seititne htrow ten hgih )II( ro )”redrO“ eht( 5002 redrO )noitomorP laicnaniF( 0002 tcA stekraM dna secivreS laicnaniF eht fo )5(91 elcitrA nihtiw gnillaf stnemtsevni ot gnitaler srettam ni ecneirepxe lanoisseforp evah ohw snosrep )I( ,ot no dessap ro deussi eb ylno yam dna ,fo esu eht rof ylelos dednetni era foereh stnetnoc ehT .ytirohtuA secivreS laicnaniF eht yb detaluger dna desirohtua si hcihw detimiL stekraM latipaC OMB yb dehsilbup si tnemucod siht KU eht nI :stnediseR .K.U oT .dtL seitiruceS snruB ttibseN OMB ro/dna .proC stekraM latipaC OMB hguorht os od dluohs niereh dessucsid ytiruces yna ni snoitcasnart tceffe ot gnihsiw nosrep .S.U ynA .laertnoM fo knaB fo seitiruces ot srefer ti taht tnetxe eht ot tpecxe ,niereh stnetnoc eht rof ytilibisnopser tpecca dna stnediser .S.U ot troper siht hsinruf ,BN OMB fo setailiffa ,.dtL seitiruceS snruB ttibseN OMB ro/dna .proC stekraM latipaC OMB :stnediseR .S.U oT .dtL/eetL snruB ttibseN OMB ro/dna .cnI snruB ttibseN OMB hguorht os od dluohs troper siht ni dedulcni seitiruces eht fo yna ni snoitcasnart tceffe ot gnihsiw nosrep naidanaC ynA .evoba tuo tes smret eht ot tcejbus niereh stnetnoc eht rof ytilibisnopser tpecca dna stnediser naidanaC ot troper siht hsinruf ,.proC stekraM latipaC OMB fo setailiffa ,.dtL/eetL snruB ttibseN OMB dna .cnI snruB ttibseN OMB :stnediseR naidanaC oT srettaM lanoitiddA .niereh dessucsid sreussi fo seitiruces lles ro yub ot ton ro rehtehw gnitaulave ni troper siht no ylelos yler ton dluohs dna tseretni fo tcilfnoc a evah yam setailiffa sti ro stekraM latipaC OMB taht emussa dluohs redaer ehT .noereht desab stnemurtsni evitavired rehto ro serutuf ,snoitpo ni ro seitiruces detaler ,niereh dessucsid seitiruces eht fo ynam ni noitisop trohs ro gnol a evah seeyolpme ro srotcerid ,sreciffo ,setailiffa sti ro stekraM latipaC OMB .sisab lapicnirp a no troper siht ni denoitnem sreussi fo seitiruces eht sremotsuc ot lles ro morf yub lliw setailiffa sti ro stekraM latipaC OMB .ytiruces yna yub ot reffo na fo noitaticilos eht ro lles ot reffo na ton si dna ylno sesoprup noitamrofni rof si lairetam sihT .rotsevni yna fo sdeen tnemtsevni ralucitrap eht teem ot dengised ecivda sa deurtsnoc eb ton dluohs ,sevitcejbo tneilc laudividni fo esuaceb dna ,snoisiced tnemtsevni fo sisab yramirp eht sa desu eb ot dednetni ton si troper siht ni noitamrofni ehT .troper siht ni detcelfer ton si taht setailiffa sti ro stekraM latipaC OMB ot elbaliava eb yam noitamrofnI .stnetnoc sti ro troper siht ,no ecnailer ro ,fo esu yna morf gnisira ssol yna rof reveostahw ytilibail on stpecca dna niereh deniatnoc snoissimo dna srorre yna rof ytilibisnopser on sekat ,foereht tcepser ni ,deilpmi ro sserpxe ,ytnarraw ro noitatneserper on sekam stekraM latipaC OMB ,revewoH .etelpmoc dna etarucca era taht snoinipo dna noitamrofni niatnoc dna elbailer era eveileb ew taht secruos morf devired ro delipmoc neeb evah stnetnoc eht taht erusne ot sruovaedne stekraM latipaC OMB .eciton tuohtiw egnahc ot tcejbus era dna troper siht fo etad eht fo sa stekraM latipaC OMB fo esoht era troper siht ni deniatnoc snoitcejorp dna setamitse ,snoinipo ehT .stekraM latipaC OMB yb derevoc sreussi ynam ,ot secivres detarenumer rehto edivorp ro ,htiw stnemegnarra gnidnel sah )”puorG laicnaniF OMB“( seiraidisbus sti ro laertnoM fo knaB .setailiffa era .proC stekraM latipaC OMB dna .dtL stekraM latipaC OMB ,.cnI snruB ttibseN OMB .S.U eht ni .proC stekraM latipaC OMB dna .K.U eht ni .dtL stekraM latipaC OMB ,.dtL/.eétL snruB ttibseN OMB dna .cnI snruB ttibseN OMB seiraidisbus sti dna laertnoM fo knaB fo mra elaselohw eht sedulcni hcihw ,puorG gniknaB tnemtsevnI OMB eht yb desu eman edart a si ”stekraM latipaC OMB“ remialcsiD lareneG .psa.cilbuP_tnemetatS_tcilfnoC/moc.stekramlatipacomb.labolghcraeser//:ptth ta elbaliava si hcihw hcraeser tnemtsevni htiw noitcennoc ni tseretni fo stcilfnoc gniganam rof ycilop gnicaf cilbup ruo ni deniatnoc si tseretni fo stcilfnoc seganam dna seifitnedi puorG laicnaniF OMB woh fo noitpircsed lareneg A tnemetatS tcilfnoC .noitamrofni erom rof nosrepselas lanoitutitsni ro rosivda tnemtsevni ruoy tcatnoc esaelP .liam raluger ro liame aiv rucco yam noitanimessid lanoitiddA .hcraeser ruo ot deltitne spuorg tneilc stekraM latipaC OMB lla ot emit emas eht ta elbaliava ylediw edam si hcraeser ruo fo llA .moc.stekraMehT dna ,QI latipaC ,teStcaF ,grebmoolB ,sretueR ,tceriD hcraeseR LLAC TSRIF ,LLAC TSRIF aiv hcraeser ruo eviecer osla yam stneilc lanoitutitsnI ./hcraeser/moc.stekramlatipacomb//:ptth etis bew ruo aiv elbaliava era snoitacilbup hcraeser ruO hcraeseR fo noitanimessiD stekraM latipaC OMB hsalF
  • 5. 5 eg aP • hsalF Financial Group A member of BMO .PROC STEKRAM LATIPAC OMB 1102 THGIRYPOC© laertnoM fo knaB kramedarT MT .erehwesle dna adanaC ,setatS detinU eht ni laertnoM fo knaB fo kramedart deretsigeR ® .esnecil rednu desu ,laertnoM fo knaB fo kramedart deretsiger a si ")lobmys lednuor raB-M( OMB" .esnecil rednu desu ,laertnoM fo knaB fo kramedart a si ”stekraM latipaC OMB“ .esnecil rednu desu ,detimiL noitaroproC snruB ttibseN OMB fo kramedart deretsiger a si ”snruB ttibseN“ .ailartsuA dna eporuE ni detimiL stekraM latipaC OMB dna ,adanaC ni )FPIC rebmeM( .dtL/eétL snruB ttibseN OMB dna ,)ARNIF fo rebmem dna deretsiger .S.U( detimiL seitiruceS snruB ttibseN OMB ,aisA dna eporuE ,adanaC ni )FPIC rebmeM( .cnI snruB ttibseN OMB ,.S.U eht ni )CPIS rebmeM( .cnI TSKG stekraM latipaC OMB dna .proC gnidarT snruB ttibseN OMB ,)CPIS rebmeM( .proC stekraM latipaC OMB fo sessenisub relaed rekorb lanoitutitsni eht dna ,clP dnalerI OMB dna .A.N sirraH ,laertnoM fo knaB fo sessenisub gniknab elaselohw eht rof puorG laicnaniF OMB yb desu eman edart a si stekraM latipaC OMB .stekraM latipaC OMB hguorht SU eht dna adanaC ni dedivorp era secivres gniknab etaroproc dna tnemtsevnI .A.N sirraH hguorht devres era stneilc liater ,setatS detinU eht nI .snruB ttibseN OMB dna laertnoM fo knaB OMB hguorht stneilc liater naidanaC sevres OMB .stcudorp gniknab etaroproc dna tnemtsevni dna ,tnemeganam htlaew ,gniknab liater fo egnar a gnireffo redivorp secivres laicnanif detargetni na si )OMB :XST ,ESYN( puorG laicnaniF OMB TSEUQER NOPU ELBALIAVA SI NOITAMROFNI LANOITIDDA stekraM latipaC OMB hsalF